4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-17-039799
CIK 0001516479operating
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 3:19 PM ET
Size
5.1 KB
Accession
0001209191-17-039799
Insider Transaction Report
Form 4
Motahari Saeed
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2017-06-14$11.10/sh+5,400$59,955→ 9,900 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.06 to $11.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 3:19 PM ET
- Size
- 5.1 KB